Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01547871 · ClinicalTrials.gov registry record

Infants With Spinal Muscular Atrophy Type I

A clinical trial, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

Terminated
Registry status
4
Enrollment target

NCT01547871: Clinical Trial study, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

NCT01547871 is a clinical trial that was terminated before completion, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 4 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01547871 was terminated before completion, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

TERMINATED
Registry status
4 participants
Enrollment target

Study Summary

Background: \- Spinal muscular atrophy type 1 (SMA 1) causes severe muscle weakness and problems with eating and breathing. The symptoms begin in infancy, and children affected with SMA 1 often die in early childhood. Researchers want to collect information on how SMA symptoms progress in first two years. Objectives: \- To study how the symptoms of SMA 1 progress in infants and children. Eligibility: \- Infants and children with SMA 1 born on or after January 1, 2007. Design: * Researchers will review the child s medical records and talk with parents by telephone. * For children who are under 2 years of age, the researchers will review the child s medical records and speak with you on telephone every 2-4 months. Phone calls with parents will take about 10 minutes and will involve questions about symptoms of SMA 1. Children will be followed until age 2.- Researchers are also interested in looking at medical records of children who are no longer alive or who are more than 2 years of age. Parents or children do not have to come to the NIH. They will provide consent to view these records, and information over the telephone. \- No treatment or care will be provided as part of this study.

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2012-02-07
Est. Completion 2016-04-14

Why NCT01547871 stopped before completion

NCT01547871 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 4 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT01547871 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01547871 about?

NCT01547871 is a clinical study titled "Infants With Spinal Muscular Atrophy Type I". Background: \- Spinal muscular atrophy type 1 (SMA 1) causes severe muscle weakness and problems with eating and breathing. The symptoms begin in infancy, and children affected with SMA 1 often die in early childhood. Researchers want to collect information on how SMA symptoms progress in first two...

What is the current status of trial NCT01547871?

This trial is currently terminated. The enrollment target is 4 participants. The study started on 2012-02-07. Estimated completion is 2016-04-14.

Who is sponsoring clinical trial NCT01547871?

This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01547871, the US trial registry maintained by the National Library of Medicine. NCT01547871 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.